Pharmaceutical News and Articles

Endotracheal Poractant Alfa Not Effective in Critical Bronchiolitis

For infants with early critical bronchiolitis, endotracheal poractant alfa does not reduce the duration of invasive mechanical ventilation compared with a sham

U.S. FDA Grants Full Approval of Kite’s Tecartus for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma

Pandemic Spurred Increase In Screen Time Among Children, Teens

THURSDAY, April 2, 2026 The COVID-19 pandemic fueled a dramatic rise in screen use among children and teenagers, a new evidence review says. Kids spent more tim

Lawsuit Over Viral David Protein Bars Dropped Without Explanation

THURSDAY, April 2, 2026 A lawsuit claiming popular protein bars had misleading nutrition labels has been dropped, but questions about the bars remain. The case

Wegovy Maker Launches Lower-Cost Subscription Plans

THURSDAY, April 2, 2026 A popular weight loss drug may soon be more affordable for some people. Danish pharmaceutical company Novo Nordisk has launched a subscr

FDA Recalls Wawa Milk Over Possible Plastic Contamination

THURSDAY, April 2, 2026 Milk sold at convenience stores in four states is being recalled amid concerns about possible plastic contamination. The U.S. Food and D

Machine Learning Model Can Predict Hepatocellular Carcinoma Risk

A machine learning model can predict hepatocellular carcinoma (HCC) risk using routinely available data, according to a study published online March 30 in Cance

ACC: Catheter-Directed Fibrinolysis Added to Anticoagulation Improves Pulmonary Embolism Outcomes

Outcomes for acute, intermediate-risk pulmonary embolism (PE) are better with ultrasound-facilitated, catheter-directed fibrinolysis plus anticoagulation versus

ACC: Intensive LDL Cholesterol Targeting Beneficial for Patients With Atherosclerotic CVD

For patients with atherosclerotic cardiovascular disease (ASCVD), targeting a low-density lipoprotein (LDL) cholesterol level of 55 mg dL results in a lower ris

ACC: Discontinuing β-Blockers Noninferior for Stabilized Acute MI

For stabilized acute myocardial infarction (AMI) without left ventricular systolic dysfunction or heart failure, discontinuing -blockers after one year or longe